- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Small Cap High Growth Stocks
Swiss Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Jul 23, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NWRNNewron Pharmaceuticals | CHF1.44 | 4.3% | -37.4% | CHF25.7m | CHF9.25 | PS4.5x | E54.6% | n/a | ||
| BSLNBasilea Pharmaceutica | CHF40.10 | 3.6% | -12.2% | CHF475.1m | CHF68.29 | PS3.2x | E52.8% | 0% | ||
| SANNSanthera Pharmaceuticals Holding | CHF0.85 | -3.9% | -63.7% | CHF44.1m | CHF5.50 | PB33.2x | E67.5% | n/a | ||
| ADXNAddex Therapeutics | CHF0.25 | 49.4% | -83.2% | CHF9.6m | n/a | PS3.9x | E34.8% | n/a |
Page 1 of 1